• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[血浆瓜氨酸浓度作为短肠综合征和肠道移植中肠道功能的生物标志物]

[Plasma citrulline concentration as a biomarker of intestinal function in short bowel syndrome and in intestinal transplant].

作者信息

Vecino López R, Andrés Moreno A M, Ramos Boluda E, Martinez-Ojinaga Nodal E, Hernanz Macías A, Prieto Bozano G, Lopez Santamaria M, Tovar Larrucea J A

机构信息

Servicio de Gastroenterología Infantil, Hospital Infantil La Paz, Madrid, España.

出版信息

An Pediatr (Barc). 2013 Oct;79(4):218-23. doi: 10.1016/j.anpedi.2013.02.007. Epub 2013 Mar 23.

DOI:10.1016/j.anpedi.2013.02.007
PMID:23528708
Abstract

INTRODUCTION

Citrulline is a non-essential amino acid produced solely in the enterocyte. The aim of this study was to analyse the role of serum citrulline as a biomarker of enterocyte load in children with intestinal failure due to short bowel syndrome (SBS) and its relationship to enteral adaptation.

MATERIAL AND METHODS

Plasma citrulline concentration was determined by chromatography (normal value>15 μmol/L) in 57 patients (age 0.5-18 years) admitted to our Intestinal Rehabilitation Unit with intestinal failure. Those who were dehydrated, with renal insufficiency, or other conditions able to modify the results were excluded. Patients were divided into 4 groups: group i: SBS totally dependent on parenteral nutrition (PN); group ii: SBS under mixed enteral-parenteral nutrition; group iii: IF weaned from PN after a rehabilitation period; group iv: small bowel transplanted patients weaned from PN and taking a normal diet.

RESULTS

The mean ± SD plasma citrulline values were: group i (n=15): 7.1 ± 4.1; group ii (n=11): 15.8 ± 8.9; group iii (n=13): 20.6 ± 7.5; group iv (n=25): 28.8 ± 10.1. Values were significantly lower in group i in comparison with groups ii-iii-iv (P<.001), and in group ii in comparison with groups iii-iv (P<.001). A low citrulline was associated with remnant small bowel length (P<.001, r=0.85). In group iv citrulline levels decreased >50% in 3 patients who developed moderate-severe rejection, and in one patient who developed viral enteritis.

CONCLUSIONS

  1. Plasma citrulline could be a sensitive and specific biomarker of the residual functional enterocyte load. 2. It is related to enteral feeding tolerance. 3. Its prognostic value in the process of intestinal adaptation and as a rejection marker in small bowel transplanted patients needs to be confirmed.
摘要

引言

瓜氨酸是一种仅在肠细胞中产生的非必需氨基酸。本研究的目的是分析血清瓜氨酸作为短肠综合征(SBS)所致肠衰竭患儿肠细胞负荷生物标志物的作用及其与肠内适应的关系。

材料与方法

对我院肠道康复科收治的57例(年龄0.5 - 18岁)肠衰竭患者,采用色谱法测定血浆瓜氨酸浓度(正常值>15μmol/L)。排除脱水、肾功能不全或其他可能影响结果的情况。患者分为4组:i组:完全依赖肠外营养(PN)的SBS患者;ii组:接受肠内 - 肠外混合营养的SBS患者;iii组:康复期后停用PN的肠衰竭患者;iv组:停用PN并正常饮食的小肠移植患者。

结果

血浆瓜氨酸均值±标准差分别为:i组(n = 15):7.1±4.1;ii组(n = 11):15.8±8.9;iii组(n = 13):20.6±7.5;iv组(n = 25):28.8±10.1。i组的值显著低于ii - iii - iv组(P<0.001),ii组的值显著低于iii - iv组(P<0.001)。低瓜氨酸与残余小肠长度相关(P<0.001,r = 0.85)。iv组中,3例发生中重度排斥反应的患者以及1例发生病毒性肠炎的患者瓜氨酸水平下降>50%。

结论

  1. 血浆瓜氨酸可能是残余功能性肠细胞负荷的敏感且特异的生物标志物。2. 它与肠内喂养耐受性有关。3. 其在肠道适应过程中的预后价值以及作为小肠移植患者排斥反应标志物的价值有待证实。

相似文献

1
[Plasma citrulline concentration as a biomarker of intestinal function in short bowel syndrome and in intestinal transplant].[血浆瓜氨酸浓度作为短肠综合征和肠道移植中肠道功能的生物标志物]
An Pediatr (Barc). 2013 Oct;79(4):218-23. doi: 10.1016/j.anpedi.2013.02.007. Epub 2013 Mar 23.
2
Plasma citrulline concentration as a biomarker for bowel loss and adaptation in hospitalized pediatric patients requiring parenteral nutrition.血浆瓜氨酸浓度作为需要肠外营养的住院儿科患者肠丢失和适应的生物标志物。
Nutr Clin Pract. 2011 Dec;26(6):681-7. doi: 10.1177/0884533611425682.
3
Plasma citrulline concentration reflects enterocyte mass in children with short bowel syndrome.血浆瓜氨酸浓度反映短肠综合征患儿的肠上皮细胞质量。
Pediatr Res. 2009 May;65(5):559-63. doi: 10.1203/PDR.0b013e31819986da.
4
Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction.瓜氨酸作为因肠细胞数量减少导致肠衰竭的生物标志物。
Clin Nutr. 2008 Jun;27(3):328-39. doi: 10.1016/j.clnu.2008.02.005. Epub 2008 Apr 28.
5
Serum citrulline levels correlate with enteral tolerance and bowel length in infants with short bowel syndrome.血清瓜氨酸水平与短肠综合征患儿的肠内耐受性和肠长度相关。
J Pediatr. 2005 Apr;146(4):542-7. doi: 10.1016/j.jpeds.2004.12.027.
6
Poor diagnostic accuracy of a single fasting plasma citrulline concentration to assess intestinal energy absorption capacity.单次空腹血浆瓜氨酸浓度评估肠道能量吸收能力的诊断准确性较差。
Am J Gastroenterol. 2007 Dec;102(12):2814-9. doi: 10.1111/j.1572-0241.2007.01513.x.
7
Serum citrulline is a simple quantitative marker for small intestinal enterocytes mass and absorption function in short bowel patients.血清瓜氨酸是短肠患者小肠肠细胞质量和吸收功能的一种简单定量标志物。
J Surg Res. 2005 Aug;127(2):177-82. doi: 10.1016/j.jss.2005.04.004.
8
Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure.特度鲁肽可减少短肠综合征伴肠衰竭患者对肠外支持的需求。
Gastroenterology. 2012 Dec;143(6):1473-1481.e3. doi: 10.1053/j.gastro.2012.09.007. Epub 2012 Sep 11.
9
Variation of plasma citrulline as a predictive factor for weaning off long-term parenteral nutrition in children with neonatal short bowel syndrome.血浆瓜氨酸变化作为新生儿短肠综合征患儿长期肠外营养撤机预测因素的研究
Clin Nutr. 2021 Aug;40(8):4941-4947. doi: 10.1016/j.clnu.2021.07.017. Epub 2021 Jul 18.
10
Assessment and outcome of children with intestinal failure referred for intestinal transplantation.接受肠道移植的肠衰竭患儿的评估与预后
Clin Nutr. 2015 Jun;34(3):428-35. doi: 10.1016/j.clnu.2014.04.015. Epub 2014 Apr 30.

引用本文的文献

1
Preclinical Study of DCD and Normothermic Perfusion for Visceral Transplantation.DCD 与常温灌流用于器官移植的临床前研究。
Transpl Int. 2023 Sep 8;36:11518. doi: 10.3389/ti.2023.11518. eCollection 2023.
2
Citrulline, Biomarker of Enterocyte Functional Mass and Dietary Supplement. Metabolism, Transport, and Current Evidence for Clinical Use.瓜氨酸:肠细胞功能量的生物标志物和膳食补充剂。代谢、转运和临床应用的当前证据。
Nutrients. 2021 Aug 15;13(8):2794. doi: 10.3390/nu13082794.